Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

A new meta-analysis revealed that the efficacy of MRI-guided focused ultrasound decreased over time in essential tremor, with sensory symptoms and unsteadiness as common adverse effects.

MRI-Guided Focused Ultrasound Demonstrates Efficacy for Essential Tremor, But Effect Decreases Over Time

Videos

The division chief of neurology at Nemours Children’s Hospital discussed evolving surgical techniques, neuromodulation therapies, and precision medicine approaches for complex epilepsy cases. [WATCH TIME: 5 minutes]

Advances in Surgical and Neuromodulation Strategies for Epilepsy Management: Satyanarayana Gedela, MD

A recently published meta-analysis reported that fatty acid supplementation, particularly omega-3, may significantly reduce severity, duration, and frequency of migraine in patients.

Meta-Analysis Reveals Fatty Acid Supplementation Linked to Migraine Symptom Improvement

Pooled analysis from KINECT-3 and KINECT-4 confirms valbenazine’s long-term safety and efficacy in managing tardive dyskinesia in elderly patients.

Valbenazine Safe and Effective for Long-Term Treatment of Tardive Dyskinesia in Elders

, has been with the team since September 2022. Follow her on Twitter 

Bruce Bebo, PhD, and Amit Bar-Or, MD, FRCPC, FAAN, FANA, discussed the impact of the John Dystel Prize on multiple sclerosis research and its role in shaping future clinical advancements. 

Advancing MS Research Through Recognition and Innovation: The John Dystel Prize

Founder and Executive Director, Sumaira Foundation

The founder and executive director of the Sumaira Foundation emphasized the critical role of lifestyle factors such as sleep, exercise, and nutrition for maintaining brain health in patients with NMOSD. [WATCH TIME: 3 minutes]

Prioritizing Brain Health in NMOSD Beyond Disease-Modifying Therapies: Sumaira Ahmed

Division Chief of Neurology, Dayton Children's Hospital

The division chief of child neurology at Dayton Children’s Hospital discussed findings from a study comparing patient satisfaction scores between telehealth and in-person visits in pediatric epilepsy care. [WATCH TIME: 4 minutes]

Comparable Evidence of Telehealth Benefits vs In-Person Care for Pediatrics: Gogi Kumar, MD

Interim chief executive officer of the Consortium of Multiple Sclerosis Centers.

IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).

IJMSC Insights: Kathleen Costello, Interim CEO of CMSC

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAN 2025

AD/PD 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Alzheimer’s Disease Treatment Landscape Evolutions

Management of Alzheimer’s Disease with FDA-approved Disease-modifying Therapies

Evolving Pathophysiology of Alzheimer’s Disease

Emerging Agents for Treatment of Alzheimer’s Disease

Symptom Management Agents for Patients with Alzheimer’s Disease

Biomarkers in Alzheimer’s Disease

Future Outlook of Alzheimer’s Disease

Lasso - DMD Peers and Perspectives NSP-21-NRD0157

 video series brings together pairs of expert clinicians and physicians to independently provide their insights on the latest and most up-to-date clinical care for specific neurologic diseases and disorders.

Management of Alzheimer’s Disease with FDA-approved Disease-modifying Therapies

EP: 1.Evolving Pathophysiology of Alzheimer’s Disease

EP: 2.Management of Alzheimer’s Disease with FDA-approved Disease-modifying Therapies

EP: 3.Emerging Agents for Treatment of Alzheimer’s Disease

EP: 4.Symptom Management Agents for Patients with Alzheimer’s Disease

EP: 5.Biomarkers in Alzheimer’s Disease

EP: 6.Future Outlook of Alzheimer’s Disease